Overview
Therese Le Treut practices practicing medicine in Marseille, France.
Her clinical expertise encompasses Sezary Syndrome, Cutaneous T-Cell Lymphoma (CTCL), and T-Cell Lymphoma.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Therese Le Treut
Is Therese Le Treut a top-rated expert for Sezary Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Therese Le Treut is classified as an Experienced expert for Sezary Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Therese Le Treut participate in research or clinical trials?
Yes. Therese Le Treut has published 9 articles and abstracts on conditions like Sezary Syndrome. You can view a list of Therese Le Treut's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Le Treut isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Sezary SyndromeMs. Le Treut isExperienced. Learn about Sezary Syndrome.
- T-Cell LymphomaMs. Le Treut isExperienced. Learn about T-Cell Lymphoma.